April 9, 2016


HIV New and updated CDC resources on HIV and AIDS

  • Dear Colleague: CDC Releases New HIV Surveillance Reports
    on May 23, 2023 at 8:00 pm

    CDC's Division of HIV Prevention released three new HIV surveillance reports.

  • 2021 HIV Mortality Slides
    on May 23, 2023 at 6:00 pm

    The 2021 HIV Mortality Slide Set outlines trends in mortality in the United States, focusing on deaths attributed to HIV disease. Among persons with HIV disease as the underlying cause of death in 2021, males, Black and African American persons, residents of the South, and persons aged 45 years and older were the most impacted.

  • HIV Infection, Stage 3 (AIDS) - 2021
    on May 23, 2023 at 6:00 pm

    This slide set describes rates, percentages, and trends in the number (including cumulative data) of stage 3 (AIDS) classifications and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) in the United States and 6 dependent areas.

  • Core Indicators for Monitoring the Ending the HIV Epidemic Initiative, National HIV Surveillance System Data Reported through December 2022 and PrEP Data Reported through September 2022
    on May 23, 2023 at 6:00 pm

    The HIV surveillance data tables provide National the latest available data on the six indicators used for monitoring progress in the Ending the HIV Epidemic in the U.S. initiative.

  • Monitoring Selected National HIV Prevention and Care Objectives, 2021
    on May 23, 2023 at 6:00 pm

    This report complements the HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System (NHSS) data to measure progress toward achieving national HIV prevention and care goals. Data are presented among persons with diagnosed, perinatally acquired HIV infection and persons aged ≥13 years with diagnosed HIV for linkage to care, receipt of care, viral suppression; stage 3 (AIDS) at the time of diagnosis of HIV infection; and death and survival of persons with diagnosed HIV infection by selected characteristics that include gender (or assigned sex at birth where indicated), age, race/ethnicity, and transmission category (based on assigned sex at birth). For preexposure prophylaxis (PrEP), the number of persons who have been prescribed PrEP, the estimated number with PrEP indications, and PrEP coverage are presented. This report also presents the status and HIV-related disparities for linkage to care, viral suppression, and PrEP coverage.

Valley STD Home